2005•Fujian Yike Daxue xuebaoRequires access

Effects of Interleukin-10 on Expression of α-Smooth Muscle Actin and Nuclear Factor-κB in Hepatic Stellate Cells in Fibrotic Rat Liver

Wang Xiaozhong

Open publisher page 0 citations

Abstract

Objective To study the effects of interleukin-10 on the expression of α-smooth muscle actin(α-SMA) and nuclear factor-κB(NF-κB) in hepatic stellate cells in experimental rat hepatic fibrosis. Methods 60 SD rats were divided into control group(group N), the model group(group C) and the IL-10 treated group(group I) randomly. Rat hepatic fibrosis model induced by CCl 4 was established, and treated with IL-10 from the 3rd week. Hepatic stellate cells were isolated from these rats at the 7th and 11th weeks during the course of liver fibrosis, respectively. The expression of α-SMA and NF-κB in HSC were measured by S-P immunohistochemistry. Results The positive expression of α-SMA and NF-κB in group N was 36.5% and 28.5% respectively and the positive immunochemical score was (0.64±0.05) and (0.43±0.08) respectively. The positive levels for α-SMA and NF-κB in group C were increased significantly compare to group N(P0.01). Their positive score in group C in the 7th week was (2.43±0.03) and (1.73±0.09), respectively, in the 11th week the score was (2.47±0.14) and (2.48±0.70), respectively. The positive score decreased significantly(P0.05) in group I. In the 7th week and the 11th week, their positive score was (2.14±0.11) and (1.62±0.10), (2.09±0.06) and (1.92±0.42), respectively. In the 11th week, the HSC in group Ⅰ became round and the nuclear pyknosis. Conclusion The positive expression of α-SMA and NF-κB in hepatic stellate cells was decreased by ectogenic IL-10 in liver fibrosis induced by CCl 4. The IL-10 inhibit the activation of hepatic stellate cells.

About this research paper

What this paper is about

Objective To study the effects of interleukin-10 on the expression of α-smooth muscle actin(α-SMA) and nuclear factor-κB(NF-κB) in hepatic stellate cells in experimental rat hepatic fibrosis. Methods 60 SD rats were divided into control group(group N), the model group(group C) and the IL-10 treated group(group I) randomly. Rat hepatic fibrosis model induced by CCl 4 was established, and treated with IL-10 from the 3rd week. Hepatic stellate cells were isolated from these rats at the 7th and 11th weeks during the course of liver fibrosis, respectively. The expression of α-SMA and NF-κB in HSC were measured by S-P immunohistochemistry. Results The positive expression of α-SMA and NF-κB in group N was 36.5% and 28.5% respectively and the positive immunochemical score was (0.64±0.05) and (0.43±0.08) respectively. The positive levels for α-SMA and NF-κB in group C were increased significantly compare to group N(P0.01). Their positive score in group C in the 7th week was (2.43±0.03) and (1.73±0.09), respectively, in the 11th week the score was (2.47±0.14) and (2.48±0.70), respectively. The positive score decreased significantly(P0.05) in group I. In the 7th week and the 11th week, their positive score was (2.14±0.11) and (1.62±0.10), (2.09±0.06) and (1.92±0.42), respectively. In the 11th week, the HSC in group Ⅰ became round and the nuclear pyknosis. Conclusion The positive expression of α-SMA and NF-κB in hepatic stellate cells was decreased by ectogenic IL-10 in liver fibrosis induced by CCl 4. The IL-10 inhibit the activation of hepatic stellate cells.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effects of interleukin-10 on the expression of α-smooth muscle actin(α-SMA) and nuclear factor-κB(NF-κB) in hepatic stellate cells in experimental rat hepatic fibrosis. Methods 60 SD rats were divided into control group(group N), the model group(group C) and the IL-10 treated group(group I) randomly. Rat hepatic fibrosis model induced by CCl 4 was established, and treated with IL-10 from the 3rd week. Hepatic stellate cells were isolated from these rats at the 7th and 11th weeks during the course of liver fibrosis, respectively. The expression of α-SMA and NF-κB in HSC were measured by S-P immunohistochemistry. Results The positive expression of α-SMA and NF-κB in group N was 36.5% and 28.5% respectively and the positive immunochemical score was (0.64±0.05) and (0.43±0.08) respectively. The positive levels for α-SMA and NF-κB in group C were increased significantly compare to group N(P0.01). Their positive score in group C in the 7th week was (2.43±0.03) and (1.73±0.09), respectively, in the 11th week the score was (2.47±0.14) and (2.48±0.70), respectively. The positive score decreased significantly(P0.05) in group I. In the 7th week and the 11th week, their positive score was (2.14±0.11) and (1.62±0.10), (2.09±0.06) and (1.92±0.42), respectively. In the 11th week, the HSC in group Ⅰ became round and the nuclear pyknosis. Conclusion The positive expression of α-SMA and NF-κB in hepatic stellate cells was decreased by ectogenic IL-10 in liver fibrosis induced by CCl 4. The IL-10 inhibit the activation of hepatic stellate cells.

Key concepts: Hepatic stellate cell, Immunohistochemistry, Internal medicine, Hepatic fibrosis, Liver fibrosis, Fibrosis, Endocrinology, Group B

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Interleukin-10 on Expression of α-Smooth Muscle Actin and Nuclear Factor-κB in Hepatic Stellate Cells in Fibrotic Rat Liver — Research Paper | ScholarLens